Daewoong Pharmaceutical (South Korea)

Recent papers from Daewoong Pharmaceutical (South Korea)

1. Umbilical cord-derived mesenchymal stem cell secretome in combination therapy for acute ankle ligament injuries: a two-patient case seriesJournal of Medical Case Reports · 2026
2. Pharmacokinetic and pharmacodynamic interaction of enavogliflozin, a sodium‐glucose cotransporter 2 inhibitor, with glimepiride and metformin in healthy participantsBritish Journal of Clinical Pharmacology · 2026
3. Comparative effects of enavogliflozin versus dapagliflozin on adipokines in patients with type 2 diabetes mellitus: a pooled analysis of two randomized controlled trialsCardiovascular Diabetology · 2026
4. Amelioration of Cancer Cachexia‐Induced Muscle Atrophy and Adipose Tissue Wasting by a Combination of Amaranth ( Amaranthus caudatus L.) Hydrolysate and Korean Mint ( Agastache rugosa ) Extract in BALB /c MiceFood Science & Nutrition · 2026
5. Engineering of tandem bispecific IL-7 receptor agonist antibody promoting selective T cell expansionProtein Engineering Design and Selection · 2026
6. Enavogliflozin Improves Non‐invasive Hepatic Steatosis Indices in Patients With Type 2 Diabetes: A Pooled Analysis of Three Randomised TrialsDiabetes Obesity and Metabolism · 2026
7. Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral InfectionsInternational Journal of Molecular Sciences · 2026
8. Establishing Primary Structure Comparability Between ABP-450 (probotulinumtoxinA) and OnabotulinumtoxinA (Botox®) to Support Biosimilarity (P11-7.010)Neurology · 2026
9. Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing SurveillanceGut and Liver · 2026
10. Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal AdenocarcinomaCancer Research · 2026
11. Abstract 7091: DWP216, a TEAD1/2 inhibitor, enhances efficacy of diverse KRAS inhibitors by reversing resistance mechanisms in RAS-dependent cancersCancer Research · 2026
12. Abstract 5776: Discovery of an orally bioavailable AKT degrader with sustained in vivo efficacy and translational potentialCancer Research · 2026
13. Efficacy and safety of a novel sodium picosulfate oral tablet in a randomized controlled trial for bowel preparationWorld Journal of Gastroenterology · 2026
14. Standardized alkali-treated Euglena gracilis β-glucan mitigates PM2.5-induced pulmonary and cerebral injury through NF-κB, NRF2, and CREB–BDNF–TrkB pathwaysJournal of Ethnopharmacology · 2026
15. A Combination of Amaranth Protein Hydrolysate and Korean Mint Extract Ameliorates Cisplatin-Induced Nephrotoxicity and Cachexia in CT26 Tumor-Bearing BALB/c MiceNutrients · 2026
16. A Nasal Spray Combining Camostat with a Natural Polysaccharide for the Prevention of Viral Infection via Nasal Mucosal Barrier Formation and Entry InhibitionInternational Journal of Molecular Sciences · 2026
17. Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialJournal of Korean Medical Science · 2026
18. Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean SubjectsClinical and Translational Science · 2025
19. Crystal structure of Fis1 and Bap31 provides information on protein-protein interactions at mitochondria-associated ER membranesCommunications Biology · 2025
20. Cholesterol-Lowering Effects of BMS-303141 Analogues via Inhibition of Adenosine Triphosphate-Citrate LyaseCurrent Pharmaceutical Design · 2025